NUCANA
NuCana is a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer by applying our phosphoramidate chemistry technology to transform some of the most widely prescribed chemotherapy agents into more effective and safer medicines.
NUCANA
Social Links:
Industry:
Clinical Trials
Founded:
2008-01-01
Address:
Edinburgh, Edinburgh, City Of, United Kingdom
Country:
United Kingdom
Website Url:
http://www.nucana.com
Total Employee:
11+
Status:
Active
Contact:
+44 (0)131 357 1111
Email Addresses:
[email protected]
Total Funding:
67.4 M USD
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Humanetics Corporation
clinical stage pharmaceutical company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Current Employees Featured
Founder
Investors List
Alida Capital International
Alida Capital International investment in Series B - NuCana
Sofinnova Investments
Sofinnova Investments investment in Series B - NuCana
Scottish Enterprise
Scottish Enterprise investment in Series B - NuCana
Morningside Ventures
Morningside Ventures investment in Series B - NuCana
Sofinnova Partners
Sofinnova Partners investment in Series B - NuCana
Alida Capital International
Alida Capital International investment in Series A - NuCana
Morningside Ventures
Morningside Ventures investment in Series A - NuCana
Sofinnova Partners
Sofinnova Partners investment in Series A - NuCana
Scottish Investment Bank
Scottish Investment Bank investment in Series A - NuCana
Official Site Inspections
http://www.nucana.com Semrush global rank: 6.82 M Semrush visits lastest month: 760
- Host name: 64.98.135.33
- IP address: 64.98.135.33
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto
More informations about "NuCana"
NuCana - Crunchbase Company Profile & Funding
NuCana is a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer by applying our …See details»
NuCana Company Profile - Office Locations, Competitors, Revenue …
Oct 29, 2024 NuCana has 5 employees across 3 locations. See insights on NuCana including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
NuCana plc - LinkedIn
NuCana is a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer by applying our phosphoramidate chemistry …See details»
NuCana - 2025 Company Profile - Tracxn
Jul 22, 2025 NuCana - Clinical-stage biopharmaceutical company developing novel nucleotide analogs to make chemotherapy agents effective and safe. Public Company. Raised a total …See details»
NuCana plc (NCNA): history, ownership, mission, how it …
Nucana Plc (NCNA) works to develop innovative cancer treatments. Learn about its history, ownership, mission, and revenue strategies in this detailed guide.See details»
NuCana - Org Chart, Teams, Culture & Jobs | The Org
View NuCana's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Investor Relations | NuCana plc
The Investor Relations website contains information about NuCana plc's business for stockholders, potential investors, and financial analysts.See details»
NuCana - businessabc.net
Aug 10, 2025 NuCana plc was founded in 2014 in Scotland by Dr. Hugh Griffith and Prof. Danny Altmann. The company’s headquarters are now located in Edinburgh, Scotland with an office …See details»
NuCana - Sofinnova Partners
Jun 29, 2015 NuCana [NCNA] is an oncology focused Biopharma company dedicated to the development and commercialization of new medicines to …See details»
NuCana Plc
NuCana Policy for Expanded Access / Compassionate Use of ProTides NuCana is focused on significantly improving treatment outcomes for patients with cancer. Our ProTides are …See details»
NuCana plc - ProTide technology to transform some of the most …
As the head of NuCana’s preclinical and translational research programme, David’s research bridges from key biological differentiators of ProTides over traditional nucleoside analogs to …See details»
NuCana Reports First Quarter 2025 Financial Results and Provides ...
Jun 2, 2025 The Investor Relations website contains information about NuCana plc's business for stockholders, potential investors, and financial analysts.See details»
SEC Filings - NuCana plc
The Investor Relations website contains information about NuCana plc's business for stockholders, potential investors, and financial analysts.See details»
News Releases | Investor Relations | NuCana plc
The Investor Relations website contains information about NuCana plc's business for stockholders, potential investors, and financial analysts.See details»
NuCana plc - ProTide technology to transform some of the most …
NuCana plc - ProTide technology to transform some of the most widely prescribed chemotherapy / cancer agentsOur new anti-cancer agents have the potential to change the standards of care …See details»
NuCana Reports First Quarter 2025 Financial Results and Provides ...
About NuCana NuCana is a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer by applying our ProTide technology to …See details»
Contact IR | NuCana plc
The Investor Relations website contains information about NuCana plc's business for stockholders, potential investors, and financial analysts.See details»
NuCana plc - ProTide technology to transform some of the most …
NuCana plc - ProTide technology to transform some of the most widely prescribed chemotherapy / cancer agentsFebruary 2013 NuCana Ups and Downs of a Drug Hunter - from the Lab to …See details»
NuCana Reports Q2 2025 Financial Results Highlighting Operating …
On August 20, 2025, NuCana plc announced its financial results for the second quarter of 2025. The company reported a significant operating loss, with research and development expenses ...See details»
NuCana Reports Second Quarter 2025 Financial Results and …
1 day ago EDINBURGH, United Kingdom, Aug. 20, 2025 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) (“NuCana” or the “Company”) announced financial results for the second …See details»